ZYBT
NASDAQ · Pharmaceuticals
Zhengye Biotechnology Holdin
$0.79
+0.07 (+10.27%)
Open$0.73
Previous Close$0.72
Day High$0.82
Day Low$0.72
52W High$13.08
52W Low$0.68
Volume—
Avg Volume364.5K
Market Cap22.29M
P/E Ratio—
EPS$-1.93
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.95M | 12.11M | 10.68M |
| Net Income | -43,750,469 | 2.69M | 1.92M |
| Profit Margin | -60.0% | 22.3% | 18.0% |
| EBITDA | -27,975,602 | 3.66M | 3.67M |
| Free Cash Flow | — | 1.61M | 1.47M |
| Rev Growth | +664.7% | -0.1% | -5.4% |
| Debt/Equity | 0.30 | 0.37 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |